Due Diligence and Art

Due Diligence and Art

Share this post

Due Diligence and Art
Due Diligence and Art
New FDA guidance for pharma on "countering misinformation" online
mRNA, Gene Therapies and Biomanufacturing Fraud

New FDA guidance for pharma on "countering misinformation" online

FDA authorizes pharmas to lie when needed, promising non-enforcement of pharmaceutical marketing regs. I interpret this as we are winning the information war.

Sasha Latypova's avatar
Sasha Latypova
Jul 26, 2024
∙ Paid
316

Share this post

Due Diligence and Art
Due Diligence and Art
New FDA guidance for pharma on "countering misinformation" online
187
40
Share

Endpoint News:

The FDA on Monday laid out its latest expectations for how pharma companies can correct misinformation spreading online about their medical products.

The draft guidance, which comes in the form of a Q&A and reworks a similar version from 2014, is the latest in a series of FDA efforts to combat misinformation more broadly, which FDA Commissi…

Keep reading with a 7-day free trial

Subscribe to Due Diligence and Art to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Sasha Latypova
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share